trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Pharmaceutical drug names follow systematic nomenclature rules set by regulatory authorities and the INN

the verdict
SUPPORTED
the evidence backs this
Recorded sources
2 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that pharmaceutical drug names follow systematic nomenclature rules set by regulatory authorities and the INN?

Yes. Pharmaceutical drug names follow systematic nomenclature rules and guidelines established by regulatory authorities and international bodies such as the World Health Organization's INN program.

Verdict: SUPPORTED · 2 sources for, 0 against · Last checked

The analysis

The claim states that pharmaceutical drug names follow systematic nomenclature rules set by regulatory authorities and the INN. Retrieved papers [3] and [11] explicitly discuss the assignment and systematic analysis of International Nonproprietary Names (INNs) by the World Health Organization and regulatory standards, fully supporting the claim. No papers refute this.

Evidence for · 2
Systematic analysis of the varied designs of 819 therapeutic antibodies and Fc fusion proteins assigned international nonproprietary names.
2022
Discusses the assignment of international nonproprietary names (INNs) by the World Health Organization to therapeutic antibodies based on systematic molecular analysis and nomenclature.
Get citation
I, W. & G, H. (2022). Systematic analysis of the varied designs of 819 therapeutic antibodies and Fc fusion proteins assigned international nonproprietary names.. doi.org. https://doi.org/10.1080/19420862.2022.2123299

See more details
More for · 1
The harmonization of World Health Organization International Nonproprietary Names definitions for cell and cell-based gene therapy substances: when a name is not enough
2021
Details how the World Health Organization assigns International Nonproprietary Names (INNs) to pharmaceutical substances following specific nomenclature rules and definitions.
Get citation
Loizides, U., Dominici, M., Manderson, T., Rizzi, M., Robertson, J., Koch, S. d. S. G., Timón, M., & Balocco, R. (2021). The harmonization of World Health Organization International Nonproprietary Names definitions for cell and cell-based gene therapy substances: when a name is not enough. doi.org. https://doi.org/10.1016/j.jcyt.2021.02.114

Receipt History
first checked05 Aug 2026
judged → SUPPORTED · 7205 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work